1. Hattar L, Assaker JP, Aoun J, Price LL, Carrozza J, Jaber BL. Revising the maximal contrast dose for predicting acute kidney injury following coronary intervention. Am J Nephrol. 2021.
2. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, et al. 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the American College of emergency physicians, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol. 2011;57(19):1920–59.
3. Amin AP, Bach RG, Caruso ML, Kennedy KF, Spertus JA. Association of variation in contrast volume with acute kidney injury in patients undergoing percutaneous coronary intervention. JAMA Cardiol. 2017;2(9):1007–12.
4. Almendarez M, Gurm HS, Mariani J Jr, Montorfano M, Brilakis ES, Mehran R, et al. Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention. JACC Cardiovasc Interv. 2019;12(19):1877–88.
5. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86(6 Pt 1):649–52.